Autoimmune Neurological Disorders and Treatments
Autoimmune Neurological Disorders and Treatments is a research topic within Neurology. Science Explorer counts 13k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on autoimmune encephalitis, particularly the clinical characteristics, diagnostic criteria, and management of conditions such as anti-NMDA receptor encephalitis, paraneoplastic syndromes, and limbic encephalitis. It explores the role of autoantibodies, immunotherapy, and the neurological manifestations of autoimmune diseases. Additionally, it discusses specific conditions like Hashimoto encephalopathy and cognitive impairment associated with these disorders.
- Anti-NMDA Receptor Encephalitis
- Paraneoplastic Syndromes
- Autoantibodies
- Neurological Disorders
- Immunotherapy
- Limbic Encephalitis
- Diagnostic Criteria
- Neuronal Autoantigens
- Hashimoto Encephalopathy
- Cognitive Impairment
- Research works
- 13k fractional, since 1950
- In the world top 10%
- 1.3k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +27% the tick is no change
- Largest producer
United States
31% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Autoimmune Neurological Disorders and Treatments research?
By volume, the United States and China publish the most (902 and 643 works in 2022-now).
By volume, 2022-now
- 1
United States 902 works
- 2
China 643 works
- 3
Japan 263 works
- 4
India 246 works
- 5
Germany 192 works
- 6
United Kingdom 167 works
- 7
Italy 153 works
- 8
France 146 works
- 9
Spain 120 works
- 10
Türkiye 86 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Autoimmune Neurological Disorders and Treatments research?
By volume in 2022-now, Mayo Clinic publishes the most Autoimmune Neurological Disorders and Treatments research, followed by Capital Medical University and Harvard University.
By volume, 2022-now
- 1
Mayo Clinic
United States 58 works
- 2
Capital Medical University
China 37 works
- 3
Harvard University
United States 30 works
- 4
Sichuan University
China 29 works
- 5
All India Institute of Medical Sciences
India 28 works
- 6
Johns Hopkins University
United States 26 works
- 7
Inserm
France 23 works
- 8
Centre National de la Recherche Scientifique
France 22 works
- 9
Zhengzhou University
China 22 works
- 10
The University of Sydney
Australia 21 works
Who are the leading researchers in Autoimmune Neurological Disorders and Treatments?
The most-cited researchers publishing on Autoimmune Neurological Disorders and Treatments include Gregory Y.H. Lip, Karl John Friston and John Q. Trojanowski.
- 1
Gregory Y.H. Lip
United Kingdom 311k citations
- 2
Karl John Friston
United Kingdom 310k citations
- 3
John Q. Trojanowski
United States 286k citations
- 4
Kaj Blennow
Sweden 247k citations
- 5
John Hardy
United Kingdom 243k citations
- 6
John C. Morris
United States 241k citations
- 7
Dennis W. Dickson
United States 237k citations
- 8
Matthew James Page
Australia 235k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Autoimmune Neurological Disorders and Treatments research done?
The largest centres of Autoimmune Neurological Disorders and Treatments research in 2022-now are Beijing (China), London (United Kingdom), Tokyo (Japan) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Rochester, Scottsdale and Cleveland.
Largest cities, 2022-now
Where it is the local speciality
- RochesterUS · 20.5 works13×
- ScottsdaleUS · 20.3 works11×
- ClevelandUS · 32.0 works5.8×
Location quotient: how much more of its research is in Autoimmune Neurological Disorders and Treatments than the world average.
Where is the best place to study Autoimmune Neurological Disorders and Treatments?
Among universities, judged by research, Johns Hopkins University, Erasmus University Rotterdam and Universitat de Barcelona score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Autoimmune Neurological Disorders and Treatments, country by countryIs Autoimmune Neurological Disorders and Treatments research growing?
Output in 2022-2025 was 27% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Autoimmune Neurological Disorders and Treatments.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Autoimmune Neurological Disorders and Treatments as a percentage of every work published that year, 0.014% in 2024.
Fractional works of Autoimmune Neurological Disorders and Treatments over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Autoimmune Neurological Disorders and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.